OIM
Oracle Investment Management Portfolio holdings
AUM
$116M
This Quarter Return
-2.13%
1 Year Return
+84.31%
3 Year Return
+539.5%
5 Year Return
+791.07%
10 Year Return
+13,222.09%
AUM
$681M
AUM Growth
+$681M
(-14%)
Cap. Flow
-$56.7M
Cap. Flow
% of AUM
-8.33%
Top 10 Holdings %
Top 10 Hldgs %
93.38%
Holding
35
New
2
Increased
2
Reduced
15
Closed
9
Top Buys
| 1 |
Pfizer
PFE
|
$28M |
| 2 |
Cross Country Healthcare
CCRN
|
$1.97M |
| 3 |
CFRX
ContraFect Corporation
CFRX
|
$693K |
| 4 |
Forian
FORA
|
$178K |
Top Sells
| 1 |
Vir Biotechnology
VIR
|
$13.4M |
| 2 |
Atea Pharmaceuticals
AVIR
|
$10.8M |
| 3 |
Y-mAbs Therapeutics
YMAB
|
$9.01M |
| 4 |
Guardant Health
GH
|
$8.75M |
| 5 |
QuidelOrtho
QDEL
|
$6.96M |
Sector Composition
| 1 | Healthcare | 100% |
| 2 | Energy | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Centene
CNC
$14.3B
| – | – |
0
| – | – |
|
27
Eli Lilly
LLY
$657B
| – | – |
0
| – | – |
|
28
Madrigal Pharmaceuticals
MDGL
$9.76B
| – | – |
-38,500
| Closed | -$3.07M |
|
29
Invesco QQQ Trust
QQQ
$364B
| – | – |
0
| – | – |
|
30
Select Medical
SEM
$1.61B
| – | – |
-149,678
| Closed | -$5.41M |
|
31
SPDR S&P 500 ETF Trust
SPY
$658B
| – | – |
0
| – | – |
|
32
XBiotech
XBIT
$96.3M
| – | – |
-350,000
| Closed | -$275K |
|
|
33
Y-mAbs Therapeutics
YMAB
$388M
| – | – |
-315,642
| Closed | -$9.01M |
|
|
VTNR
34
DELISTED
Vertex Energy, Inc
VTNR
| – | – |
-90,000
| Closed | -$472K |
|
|
35
Guardant Health
GH
$8.41B
| – | – |
-70,000
| Closed | -$8.75M |
|